retatrutide status fda Approval 2026: Everything We Know So Far Retatrutide, an experimental weight-loss drug,

Kidney or Liver Disease: Patients with impaired renal or hepatic function should consult their doctor, as L-arginine can affect potassium levels (potentially leading to hyperkalemia)

Tools like a continuous glucose monitor and the Signos app can add another layer of support, helping you spot patterns and see how your body responds day to day

For many people, this leads to clear and sustainable weight loss when combined with lifestyle support

Key differences between Zepbound and Wegovy While these two weight-loss medications both fall under the class of GLP-1 drugs, they differ in key ways and it may impact which is right for you

Niketa Dr